References
- Bouroncle B. A., Doan C. A., Wiseman B. K. Evaluation of the effect of massive prednisolone therapy in acute leukaemia. Acta Haematologica 1959; 22: 201–208
- Burningham R. A., Restrepo A., Pugh R. P., Brown E. B., Schlossman S. E., Khuri P. D., Lessner H. E., Harrington W. J. Weekly high-dosage glucocorticosteroid treatment of lymphocytic leukemias and lymphomas. New England Journal of Medicine 1964; 270: 1160–1166
- Catovsky D., Richards S., Fooks J., Hamblin T. J. CLL trials in the United Kingdom. The Medical Research Council CLL Trials 1, 2 and 3. Leukemia and Lymphoma 1991; 105–112, Supplement
- Sawitsky A., Rai K. R., Glidewell O., Silver R. T. Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia. Blood 1977; 50: 1049–1059
- Ryalls M. R., Pinkerton C. R., Meller S. T., Talbot D., McElwain T. J. High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia. Medical Pediatric Oncology 1992; 20: 119–123
- Liu Yin J. A., Narayanan N. N., Love E. M., Geary C. G., Delamore I. W., MacIver J. E. Pulse high dose methyl prednisolone in the treatment of refractory and end-stage chronic lymphocytic leukaemia (CLL). British Journal of Haematology 1988; 69: 143
- Bosanquet A. G., McCann S. R., Crotty G. M., Mills M. J., Catovsky D. Methylprednisolone in advanced chronic lymphocytic leukaemia: rationale for, and effectiveness of treatment suggested by DiSC assay. Acta Haematologica 1995; 93: 73–79
- Dowling P. C., Bosch V. V., Cook S. D. Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis. Neurology 1980; 30: 33–36
- Arsura E., Brunner N. G., Namba T., Grob D. High-dose intravenous methylprednisolone in myasthenia gravis. Archives of Neurology 1985; 42: 1149–1153
- Baylis E. M., Williams I. A., English J., Marks V., Chakraborty J. High dose intravenous methylprednisolone “pulse” therapy in patients with rheumatoid disease. Plasma methylprednisolone levels and adrenal function. European Journal of Clinical Pharmacology 1982; 21: 385–388
- Forgeson G. V., Selby P., Lakhani S., Zulian G., Viner C., Maitland J., McElwain T. J. Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients. British Journal of Cancer 1988; 58: 469–473
- Velasquez W. S., McLaughlin P., Tucker S., Hagemeister F. B., Swan F., Rodriguez M. A., Romaguera J., Rubenstein E., Cabanillas F. ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study. Journal of Clinical Oncology 1994; 12: 1169–1176
- Garret R., Paulus H. Complications of intravenous methylprednisolone pulse therapy. Arthritis and Rheumatism (abstr) 1980; 23: 677